SCHEMBL13757073

SCHEMBL13757073

O=C(Nc1nccs1)[C@]1(c2cccc(S(=O)(=O)NCCc3ccccn3)c2)C[C@H]1C1CCCCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GCK P35557 4/20 0.57
▸ TSHR P16473 3/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ STAT3 P40763 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ RAB9A P51151 1/20 0.40
▸ PRMT5 O14744 1/20 0.40
▸ WDR77 Q9BQA1 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.38
▸ PKM P14618 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPK1 P28482 1/20 0.37
▸ SCN3A Q9NY46 1/20 0.37
▸ NR3C1 P04150 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1582051 1.00 GCK (0.57) GCKTSHRMEN1KMT2ASMN1; SMN2
SCHEMBL13757074 0.92 GCK (0.67) GCKTSHRMEN1KMT2ASMN1; SMN2
SCHEMBL1582066 0.92 GCK (0.67) GCKTSHRMEN1KMT2ASMN1; SMN2
SCHEMBL1581520 0.91 GCK (0.65) GCKTSHRMEN1KMT2ASMN1; SMN2
SCHEMBL12720684 0.91 GCK (0.65) GCKTSHRMEN1KMT2ASMN1; SMN2
SCHEMBL13757051 0.91 GCK (0.65) GCKTSHRMEN1KMT2ASMN1; SMN2
SCHEMBL12720707 0.85 RAB9A (0.43) TSHRMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL2653135 0.82 GCK (0.80) GCKTSHRMEN1KMT2ASMN1; SMN2
SCHEMBL13757058 0.82 GCK (0.80) GCKTSHRMEN1KMT2ASMN1; SMN2
SCHEMBL12720794 0.76 GCK (0.64) GCKTSHRMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576108-B2 Substituted arylcyclopropylacetamides as glucokinase activators ELI LILLY AND COMPANY (US) 2009-08-18 — — US disclosed
US-7576108-B2 Substituted arylcyclopropylacetamides as glucokinase activators ELI LILLY AND COMPANY (US) 2009-08-18 — — US disclosed
Send feedback